| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446689 | European Journal of Cancer | 2012 | 7 Pages |
Abstract
A non-significantly better outcome was observed with CG as compared to C in patients with CUP and a non-unfavourable prognosis. The toxicity profile of the combined arm was represented by haematologic toxicity with thrombocytopenia and leuconeutropenia. International collaboration is required to conduct phase III trials in patients with CUP.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Gross-Goupil, A. Fourcade, E. Blot, N. Penel, S. Négrier, S. Culine, L. Chaigneau, T. Lesimple, F. Priou, A. Lortholary, M.C. Kaminsky, J. Provencal, E. Voog, J. Bouzy, A. Laplanche, K. Fizazi,